iBio reports FY 2026 revenue, loss
iBio reported FY 2026 revenue of $100K, net income of ($33.04M) and EPS of ($0.32) in its 10-K summary.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.